Detalles de la búsqueda
1.
Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40.
Cell Physiol Biochem
; 50(3): 1055-1067, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30355918
2.
The Protective Effects of the A/ZJU01/ PR8/2013 Split H7N9 Avian Influenza Vaccine Against Highly Pathogenic H7N9 in BALB/c Mice.
Cell Physiol Biochem
; 46(2): 633-643, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29617693
3.
Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase.
Mol Pharm
; 15(8): 3260-3271, 2018 08 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29944378
4.
Host proteins interact with viral elements and affect the life cycle of highly pathogenic avian influenza A virus H7N9.
Heliyon
; 10(7): e28218, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38560106
5.
RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells.
Curr Cancer Drug Targets
; 23(2): 103-117, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36028965
6.
RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer.
Cancer Res Treat
; 52(3): 973-986, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32324988
7.
Highly pathogenic H7N9 avian influenza virus infection associated with up-regulation of PD-1/PD-Ls pathway-related molecules.
Int Immunopharmacol
; 85: 106558, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32450532
8.
Novel pathogenic characteristics of highly pathogenic avian influenza virus H7N9: viraemia and extrapulmonary infection.
Emerg Microbes Infect
; 9(1): 962-975, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32267217
9.
Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer.
Front Oncol
; 9: 1377, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31867280
10.
Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy.
J Immunother Cancer
; 7(1): 250, 2019 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31519211
11.
Corrigendum: Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements.
Front Microbiol
; 10: 2975, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32010079
12.
Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy.
J Immunother Cancer
; 7(1): 75, 2019 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30871619
13.
Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy.
J Immunother Cancer
; 7(1): 94, 2019 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30940188
14.
RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE.
Mol Cancer Ther
; 17(12): 2654-2664, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30275241
15.
Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements.
Front Microbiol
; 9: 2724, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30483236
16.
The lifecycle of the Ebola virus in host cells.
Oncotarget
; 8(33): 55750-55759, 2017 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28903457
Resultados
1 -
16
de 16
1
Próxima >
>>